Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Neurilemmoma

• Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
• Doxycycline in Cutaneous Schwannoma (NF2)
• Nimodipine in Vestibular Schwanommas
• Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF
• Innovative Trial for Understanding the Impact of Targeted Therapies in NF2
• Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560
• Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
• Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
• AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery
• Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET
• SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
• A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer
• Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
• Study of Aspirin in Patients With Vestibular Schwannoma
• Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
• Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma
• Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors
• Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma
• Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
• A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery
• Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
• PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
• Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
• Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function
• Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function
• Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
• Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
• Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
• Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
• SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
• Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
• Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
• SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
• Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
• Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
• Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients
• Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
• Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
• A Study of Nilotinib in Growing Vestibular Schwannomas
• Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
• RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
• Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
• Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
• Concentration and Activity of Lapatinib in Vestibular Schwannomas
• Sorafenib and Dacarbazine in Soft Tissue Sarcoma
• Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
• Trial of Dasatinib in Advanced Sarcomas
• Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
• Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
• S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor